cro.directory
← Compare landing

Accelera Srl vs PharmaLegacy Laboratories

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/accelera/pharmalegacy

CategoryAccelera SrlPharmaLegacy Laboratories
Listed sitecrocro
SummaryEurope-based preclinical CRO specializing in GLP-compliant toxicology, safety assessment, and efficacy testing for small molecules and biologics, with AAALAC accreditation and integrated translational research capabilities.Preclinical CRO with over 1,500 validated in vivo efficacy models spanning 100+ indications in oncology, immunology, inflammation, and bone disease. AAALAC-accredited vivarium with capacity for 30,000 rodents and 350 non-human primates supports IND filings to FDA and CFDA.
Services
  • GLP Toxicology
  • DART (Reproductive & Developmental Toxicology)
  • Safety Pharmacology
  • In Vivo Efficacy Models
  • Preclinical In Vivo Studies
  • Translational Research
  • Regulatory Affairs
  • In Vivo Efficacy Models
  • In Vivo PK / PD Studies
  • Safety Pharmacology
  • Specialized & Large-Animal Models
  • Preclinical In Vivo Studies
  • US FDA Regulatory Strategy
  • China NMPA Regulatory Strategy
  • Translational Research
Modalities
  • Small Molecule
  • Biologics (Other)
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
Indications
  • Oncology
  • Oncology
  • Immunology
  • Rare Disease
Locations
  • Headquarters, Milan, Italy
  • Headquarters
Certifications
  • AAALAC · Identifier: AAALAC accreditation
  • GLP · Identifier: GLP compliance
Data not yet provided.
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.